Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

July 2040 1

  1. Study completion Exploring Motor Learning in Acute Stroke Through Robotics Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04171856

April 2041 1

  1. Study completion Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07321899

January 2045 1

  1. Primary completion Physician Modified Endovascular Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01538056

August 2048 1

  1. Study completion A Study of Cardiovascular Events iN Diabetes Plus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05441267

December 2049 1

  1. Study completion ORION-4 (inclisiran outcome trial)

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

January 2055 1

  1. Study completion Physician Modified Endovascular Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01538056

December 2073 1

  1. Study completion Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022587

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06645249

  2. Study completion Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06750341

  3. Study completion Nebivolol ANOCA Treatment Randomized Trial Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06755801

  4. Primary completion A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07021976

  5. Primary completion A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07100418

  6. Primary completion Pivotal Study of the Velocity™ pAVF System Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07153939

  7. Primary completion A Study to Evaluate the Safety and Effectiveness of the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System in Adults With Peripheral Artery Disease (PAD) Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07209085

  8. Study completion Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital Monitoring Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07260721

  9. Primary completion Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07384650

  10. Study start Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405671

  11. Study start triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07440381

  12. Study start Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07468448

  13. Study start Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07571447

  14. Study start GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617155

  15. Study start BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07628985

  16. Primary completion Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07648693

  17. Study start An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes. Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07661381

  18. Study start Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746271

  19. Study start Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07781462

  20. Study start Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07801599

  21. Study start KV-PREDICT Diagnostic Device in Patients With Heart Failure Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07805213

  22. Study start Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07811934

  23. Study start A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy Registry record

    Expected 2026-09-30; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816198

  24. Study start A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07833098

  25. Study start Post-Marketing Clinical Study of High-Pressure Cutting Balloon Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835178

  26. Study start OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) Registry record

    Expected 2026-09; that period ended on 2026-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07855614

  27. Primary completion Vasoactive Drugs in Intensive Care Unit Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02118467

  28. Study completion Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05930145

  29. Study completion Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029166

  30. Primary completion Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06029166

  31. Study completion REBOA in Nontraumatic OHCA Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06031623

  32. Primary completion A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06200207

  33. Primary completion Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06701825

  34. Study completion A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06972732

  35. Primary completion A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06972732

  36. Study completion Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989892

  37. Primary completion Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07200180

  38. Primary completion Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07397351

  39. Study completion Engaging Home-monitored Assessment to Navigate Clinical Decision-making Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07399912

  40. Primary completion Engaging Home-monitored Assessment to Navigate Clinical Decision-making Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07399912

  41. Primary completion VASC-AF Study: Vascular Closure vs Manual Compression Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414121

  42. Primary completion Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07508254

  43. Primary completion AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07512206

  44. Study start AI-Assisted Workflow for Occult Atrial Fibrillation Detection After Ischemic Stroke: A Prospective Randomized Trial Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07540065

  45. Study start Remote Monitoring and Optimization of Heart Failure Therapy Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07622472

  46. Study start LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07645300

  47. Study start A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07645586

  48. Study completion Effectiveness of Early Intervention With Virtual Reality-Based Interactive Rehabilitation on Upper Extremity Muscle Strength, Cognitive Status, Hospital Anxiety, and Exercise Self-Efficacy in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07674329

  49. Primary completion Effectiveness of Early Intervention With Virtual Reality-Based Interactive Rehabilitation on Upper Extremity Muscle Strength, Cognitive Status, Hospital Anxiety, and Exercise Self-Efficacy in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07674329

  50. Study start Effectiveness of Supervised and Unsupervised mHealth-based Exercise Interventions on Clinical Outcomes in Adults With Type 2 Diabetes and Obesity Within a Primary Care Context Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07685080

  51. Study start PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739537

  52. Study start Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743697

  53. Study start APEX-STROKE CALM-ICH Domain Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752719

  54. Study start Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07760922

  55. Study start Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT) Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07771491

  56. Study start Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07824492

  57. Study start EECP for Erectile Dysfunction in Elderly Hypertensive Patients Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07831551

  58. Study start Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07841080

  59. Study start Adaptation, Implementation, and Validation of an Innovative eHealth System for the Self-management, Monitoring, and Specialized Remote Medical Care of Patients With Diabetes in the Municipalities of Palermo (Huila) and Suárez (Cauca). Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07849725

  60. Study start Vortosiran in Atrial Fibrillation Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870889

  61. Study start Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877116

  62. Study start CATCH AF - Atrial Fibrillation Detection in Cryptogenic Stroke Registry record

    Expected 2026-10-01; that period ended on 2026-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899788

  63. Study completion REmote COnditioning in Out-of-Hospital Cardiac Arrest Registry record

    Expected 2026-10-05; that period ended on 2026-10-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06306625

  64. Study completion A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. Registry record

    Expected 2026-10-06; that period ended on 2026-10-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03884257

  65. Study completion RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Registry record

    Expected 2026-10-07; that period ended on 2026-10-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07203521

  66. Study start Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study Registry record

    Expected 2026-10-08; that period ended on 2026-10-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07819175

  67. Primary completion Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Registry record

    Expected 2026-10-10; that period ended on 2026-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07193459

  68. Study completion DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Registry record

    Expected 2026-10-12; that period ended on 2026-10-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05764057

  69. Primary completion DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Registry record

    Expected 2026-10-12; that period ended on 2026-10-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05764057

  70. Primary completion Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock Registry record

    Expected 2026-10-14; that period ended on 2026-10-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04184635

  71. Study completion Phimume® Percutaneous Left Ventricular Assist System Study Registry record

    Expected 2026-10-14; that period ended on 2026-10-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06639321

  72. Study completion A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE Registry record

    Expected 2026-10-15; that period ended on 2026-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05702034

  73. Primary completion A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE Registry record

    Expected 2026-10-15; that period ended on 2026-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05702034

  74. Primary completion The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile Registry record

    Expected 2026-10-15; that period ended on 2026-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06083961

  75. Study start A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension Registry record

    Expected 2026-10-15; that period ended on 2026-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647003

  76. Study start Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Registry record

    Expected 2026-10-15; that period ended on 2026-10-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07730840

  77. Study completion Heart Failure Precision Medicine Study Registry record

    Expected 2026-10-16; that period ended on 2026-10-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04196842

  78. Primary completion Heart Failure Precision Medicine Study Registry record

    Expected 2026-10-16; that period ended on 2026-10-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04196842

  79. Study completion Diabetes Clinical Decision Support Registry record

    Expected 2026-10-16; that period ended on 2026-10-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05447806

  80. Primary completion Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers Registry record

    Expected 2026-10-18; that period ended on 2026-10-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07033585

  81. Study completion Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-10-18; that period ended on 2026-10-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279493

  82. Primary completion Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Registry record

    Expected 2026-10-18; that period ended on 2026-10-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279493

  83. Study start TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention Registry record

    Expected 2026-10-19; that period ended on 2026-10-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899021

  84. Study start Evaluating a Digital Aid to Improve ICD Decisions Registry record

    Expected 2026-10-19; that period ended on 2026-10-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07913204

  85. Study start Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia Registry record

    Expected 2026-10-20; that period ended on 2026-10-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07827521

  86. Primary completion Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment Registry record

    Expected 2026-10-22; that period ended on 2026-10-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07403669

  87. Study start Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record

    Expected 2026-10-23; that period ended on 2026-10-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07632898

  88. Study start PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk Registry record

    Expected 2026-10-25; that period ended on 2026-10-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07741253

  89. Study start Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients Registry record

    Expected 2026-10-25; that period ended on 2026-10-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877103

  90. Study start Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke Registry record

    Expected 2026-10-26; that period ended on 2026-10-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07609654

  91. Study start Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli Registry record

    Expected 2026-10-26; that period ended on 2026-10-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07794306

  92. Study completion Atrasentan in Patients With Proteinuric Glomerular Diseases Registry record

    Expected 2026-10-27; that period ended on 2026-10-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04573920

  93. Study start Dynamic Stabilometry Combined With Transcranial Direct Current Stimulation for Balance and Motor Recovery After Ischemic Stroke Registry record

    Expected 2026-10-28; that period ended on 2026-10-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07912151

  94. Study completion Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Registry record

    Expected 2026-10-30; that period ended on 2026-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05469659

  95. Study completion Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery Registry record

    Expected 2026-10-30; that period ended on 2026-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06144125

  96. Study completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE Registry record

    Expected 2026-10-30; that period ended on 2026-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06189950

  97. Primary completion Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke Registry record

    Expected 2026-10-30; that period ended on 2026-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06645522